Premium
Brentuximab vedotin in multifocal cutaneous anaplastic large cell lymphoma in a patient with human immunodeficiency virus following Hodgkin lymphoma
Author(s) -
Wolf S.,
Goiriz R.,
Dhairyawan R.,
Paige D.,
Rizvi H.,
Haroon A.,
Montoto S.
Publication year - 2019
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/ced.13824
Subject(s) - brentuximab vedotin , anaplastic large cell lymphoma , lymphoma , medicine , human immunodeficiency virus (hiv) , hodgkin lymphoma , oncology , virology , dermatology , pathology
Click here for the corresponding questions to this CME article.